48m
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Not intended for UK and US audiences JASCAYD® (nerandomilast) now approved by Japan’s MHLW for the treatment of adults with idiopathic pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results